An ongoing dialogue on HIV/AIDS, infectious diseases,
October 7th, 2010
Post-Halladay Video Treat: Prospects for HIV Cure
For a little entertainment between playoff games — but how could anyone beat the guy in the picture? — you might want to check out this interview I did with Dan Kuritzkes about the prospects for an HIV cure. So which do you think we’ll see first — an HIV cure or a vaccine? And I don’t mean […]
October 1st, 2010
Five Friday Fasciolas
As we await either the start of the baseball playoffs (or Spring Training), here is some ID/HIV content to consider, in no particular order: Could adenovirus infection be the cause of obesity? That would be the media take, especially from this highly-esteemed research journal, The New York Daily News. (Warning: kind of ugly photo in […]
September 6th, 2010
Treating Cellulitis: Getting the Answer Wrong and Right
What’s the right antibiotic choice for cellulitis in the era of community-acquired MRSA? As astutely pointed out by Anne in her comment, the “correct” answer to the recertification question was #4, trimethoprim-sulfamethoxazole, for the following reason: I am not a doctor, I am a test developer. Having exactly zero knowledge about the content here (could […]
August 30th, 2010
Required Reading: In Love and “Serodiscordant”
Being of a certain age, my wife and I still subscribe to the print version of the Sunday New York Times. Since we also get the local rag, quite a bit of paper is deposited on our doorstep each week. Worth it? You bet, especially since occasionally there’s a gem in there like this week’s […]
August 26th, 2010
Lyme Cases Up — Anecdotes, True Epidemiology, and More Anecdotes
All of us New England-based ID doctors (and internists and family practitioners and pediatricians and NPs/PAs in primary care) who have been in practice a while will tell you that Lyme cases have been increasing for years. And it’s not just the number of cases, it’s also where and when they are occurring. A few years […]
August 10th, 2010
Curbside Consults: The Yin and the Yang
One of the simultaneously most enjoyable and exasperating aspects of being an Infectious Disease specialist is the large volume of “curbside” consultations we get from colleagues. For example, here’s this week’s talley — and it’s only Tuesday — done from memory and without systematically keeping track of emails, pages, phone calls, etc.: Duration of antibiotics […]
August 3rd, 2010
HIV Testing: NY Makes Progress; Massachusetts … Not So Much
From the office of New York Governor David Paterson: The Governor signed into law S.8227/A.11487, which will allow patients to agree to HIV testing as part of a general signed consent to medical care that remains in effect until it is revoked or expires. The bill will also, among other things: allow oral consent to […]
July 30th, 2010
Perinatal Transmission of HIV “Solved” — Now How Do We Pay For It?
Conspicuously absent from this year’s International AIDS Conference were major studies on prevention of maternal-to-child transmission. It could be that I just missed them, so I emailed a colleague who specializes in the area, and she concurred: Nope, did not see or hear major PMTCT updates at IAS. The thing is, this problem has been […]
July 6th, 2010
Torrid Tuesday
Some ID/HIV-related items for a sweltering summer day: Are the AIDS Drug Assistance Programs (ADAPs) in trouble? Certainly in some states they are, and this interview gives additional perspective. But I wonder — how much of this is HIV-specific, and how much is just the ongoing lousy economy. In other words, are other government-funded programs comparably stressed? […]
July 1st, 2010
RFA-AI-10-009, HIV Cure, and “Berlin Patient” Update
Interesting “RFA” (Request for Application, #RFA-AI-10-009) from Bethesda: The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH), National Institutes of Health (NIH), encourage grant applications from institutions/organizations to address the problem of HIV-1 persistence in HIV-1-infected persons treated with suppressive antiretroviral drug regimens… The goal of this […]

